CtDNA Based MRD Testing for NAC Monitoring in TNBC
Public ClinicalTrials.gov record NCT06230185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)
Study identification
- NCT ID
- NCT06230185
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Personalis Inc.
- Industry
- Enrollment
- 422 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 8, 2023
- Primary completion
- Aug 29, 2025
- Completion
- Dec 30, 2025
- Last update posted
- Jan 6, 2025
2023 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology | Tucson | Arizona | 85704 | Recruiting |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | Recruiting |
| George Washington University | Washington D.C. | District of Columbia | 20037 | Recruiting |
| Mount Sinai Medical Center of Florida | Miami Beach | Florida | 33140 | Recruiting |
| Comprehensive Hematology Oncology (ONare Alliance, LLC / Exigent Research, LLC | St. Petersburg | Florida | 33709 | Recruiting |
| Illinois Cancer Care | Peoria | Illinois | 61615 | Recruiting |
| Louisiana State University | New Orleans | Louisiana | 70112 | Recruiting |
| Trinity Health-Michigan | Ypsilanti | Michigan | 48197 | Recruiting |
| Nebraska Methodist | Omaha | Nebraska | 68114 | Recruiting |
| Stony Brook University Cancer Center | Stony Brook | New York | 11794 | Recruiting |
| Oregon Oncology Specialists | Salem | Oregon | 97301 | Recruiting |
| Cancer Care Associates of York | York | Pennsylvania | 17403 | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Cancer Care Northwest | Spokane | Washington | 99202 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06230185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06230185 live on ClinicalTrials.gov.